The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

It’s rare that FDA refuses to file an application, particularly for a new vaccine, which requires companies and FDA staff to engage in months or years of discussions.

U.S. stocks are feeling both the upside and downside of a surprisingly strong report on the U.S. job market. After initially ...